Ever Source Wealth Advisors, LLC Beam Therapeutics Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 156 shares of BEAM stock, worth $2,834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156
Previous 61
155.74%
Holding current value
$2,834
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BEAM
# of Institutions
258Shares Held
93.6MCall Options Held
425KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA9.93MShares$180 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.87MShares$161 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.48MShares$154 Million1.79% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$139 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$82.5 Million72.77% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.28B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...